Back to Capital International Investors Capital International Investors

CRSPCRSP
Showing 8 of 31 quarters

Position history for Capital International InvestorsCapital International Investors's holdings in CRISPR THERAPEUTICS AG

Capital International Investors holds 1.3M shares of CRSP (CRISPR THERAPEUTICS AG), worth $69.2M as of 2026-Q2. The position was increased (+6.9% shares). CRSP represents 0.0% of Capital International Investors's portfolio.

Current Value

$69.2M

Current Shares

1.3M

Total Value Change

-$303.2M

Total Shares Change

-6.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+6.9%
$69.2M0.0%$54.54
32
2026-Q1
Decreased
1.2M
-79.9%
$56.5M0.0%$58.06
0
2025-Q4
Increased
5.9M
+4.3%
$309M0.0%$53.19
32
2025-Q3
Increased
5.6M
+1.0%
$366.1M0.1%$63.77
31
2025-Q2
Decreased
5.6M
-7.9%
$272.1M0.0%$47.49
0
2025-Q1
Decreased
6.1M
-30.5%
$206.7M0.0%$36.99
0
2024-Q4
Increased
8.7M
+10.3%
$344.1M0.1%$38.65
34
2024-Q3
Increased
7.9M
+0.8%
$372.4M0.1%$47.32
31

Other major holders of CRSP: ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used